Document Detail


Evidence-based medicine: botulinum toxin A in migraine and tension-type headache.
MedLine Citation:
PMID:  11357239     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The therapeutic effect of botulinum toxin in headache was observed coincidentally. The rationale for this new indication initially met with a great deal of scepticism, because the toxin's mechanism of action, cholinergic chemodenervation, does not fit the pathophysiological concept of migraine and other forms of headache. Meanwhile a fair number of studies have been published which indicate efficacy for botulinum toxin and recommend its use for the treatment of tension headache and migraine. According to the evidence-based medicine criteria, grade I evidence has been demonstrated. In addition the use of botulinum toxin for cluster-headache and secondary headache is discussed. Further large scale studies will be regarded to demonstrate the long-term efficacy.
Authors:
H Göbel; A Heinze; K Heinze-Kuhn; W H Jost
Related Documents :
18021839 - Teaching evidence-based medicine in otolaryngology.
17660119 - Evidence-based medicine.
20092449 - Priapism: pathogenesis, epidemiology, and management.
9084299 - Esthetic restorations for posterior teeth: practical and clinical considerations.
18186399 - Cerebrospinal shunt malfunction: recognition and emergency management.
14524139 - Web-based classroom data collection in adhd: a best practices case study.
22318619 - The innovative medicines initiative: a european response to the innovation challenge.
16459499 - Re-engineering colles: form, function and fragility fractures.
17546309 - The availability and affordability of selected essential medicines for chronic diseases...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of neurology     Volume:  248 Suppl 1     ISSN:  0340-5354     ISO Abbreviation:  J. Neurol.     Publication Date:  2001 Apr 
Date Detail:
Created Date:  2001-05-18     Completed Date:  2001-10-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0423161     Medline TA:  J Neurol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  34-8     Citation Subset:  IM    
Affiliation:
Kiel Pain Clinic, Heikendorfer Weg 9-27 D-24149 Kiel, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Botulinum Toxin Type A / therapeutic use*
Controlled Clinical Trials as Topic / statistics & numerical data
Evidence-Based Medicine / statistics & numerical data*
Humans
Migraine Disorders / drug therapy*
Neuromuscular Agents / therapeutic use*
Tension-Type Headache / drug therapy*
Chemical
Reg. No./Substance:
0/Botulinum Toxin Type A; 0/Neuromuscular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence-based medicine: botulinum toxin in focal hyperhidrosis.
Next Document:  Botulinum toxin: evidence-based medicine criteria in rare indications.